vs
MGP INGREDIENTS INC(MGPI)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是MGP INGREDIENTS INC的1.4倍($197.9M vs $138.3M),REPLIGEN CORP净利率更高(6.7% vs -97.3%,领先104.1%),REPLIGEN CORP同比增速更快(13.6% vs -23.5%),MGP INGREDIENTS INC自由现金流更多($24.3M vs $17.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs -9.9%)
MGP配料公司是总部位于美国的优质蒸馏酒、特种小麦和玉米基淀粉及蛋白质配料供应商,服务食品饮料制造、餐饮及工业客户领域,为北美及部分全球市场客户提供定制化配料解决方案。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
MGPI vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$138.3M
营收增速更快
RGEN
高出37.1%
-23.5%
净利率更高
RGEN
高出104.1%
-97.3%
自由现金流更多
MGPI
多$6.7M
$17.6M
两年增速更快
RGEN
近两年复合增速
-9.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $138.3M | $197.9M |
| 净利润 | $-134.6M | $13.3M |
| 毛利率 | 34.9% | 52.5% |
| 营业利润率 | -97.7% | 9.0% |
| 净利率 | -97.3% | 6.7% |
| 营收同比 | -23.5% | 13.6% |
| 净利润同比 | -220.8% | 143.9% |
| 每股收益(稀释后) | $-6.23 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MGPI
RGEN
| Q4 25 | $138.3M | $197.9M | ||
| Q3 25 | $130.9M | $188.8M | ||
| Q2 25 | $145.5M | $182.4M | ||
| Q1 25 | $121.7M | $169.2M | ||
| Q4 24 | $180.8M | $174.1M | ||
| Q3 24 | $161.5M | $154.9M | ||
| Q2 24 | $190.8M | $154.1M | ||
| Q1 24 | $170.6M | $151.3M |
净利润
MGPI
RGEN
| Q4 25 | $-134.6M | $13.3M | ||
| Q3 25 | $15.4M | $14.9M | ||
| Q2 25 | $14.4M | $14.9M | ||
| Q1 25 | $-3.0M | $5.8M | ||
| Q4 24 | $-42.0M | $-30.3M | ||
| Q3 24 | $23.9M | $-654.0K | ||
| Q2 24 | $32.1M | $3.3M | ||
| Q1 24 | $20.6M | $2.1M |
毛利率
MGPI
RGEN
| Q4 25 | 34.9% | 52.5% | ||
| Q3 25 | 37.8% | 53.2% | ||
| Q2 25 | 40.1% | 50.0% | ||
| Q1 25 | 35.6% | 53.6% | ||
| Q4 24 | 41.2% | 26.1% | ||
| Q3 24 | 40.8% | 50.0% | ||
| Q2 24 | 43.6% | 49.8% | ||
| Q1 24 | 36.8% | 49.5% |
营业利润率
MGPI
RGEN
| Q4 25 | -97.7% | 9.0% | ||
| Q3 25 | 16.1% | 8.9% | ||
| Q2 25 | 14.0% | 7.6% | ||
| Q1 25 | -0.6% | 3.9% | ||
| Q4 24 | -16.8% | -17.7% | ||
| Q3 24 | 20.2% | -5.1% | ||
| Q2 24 | 22.7% | 1.0% | ||
| Q1 24 | 17.0% | 1.3% |
净利率
MGPI
RGEN
| Q4 25 | -97.3% | 6.7% | ||
| Q3 25 | 11.8% | 7.9% | ||
| Q2 25 | 9.9% | 8.2% | ||
| Q1 25 | -2.5% | 3.4% | ||
| Q4 24 | -23.2% | -17.4% | ||
| Q3 24 | 14.8% | -0.4% | ||
| Q2 24 | 16.8% | 2.2% | ||
| Q1 24 | 12.1% | 1.4% |
每股收益(稀释后)
MGPI
RGEN
| Q4 25 | $-6.23 | $0.24 | ||
| Q3 25 | $0.71 | $0.26 | ||
| Q2 25 | $0.67 | $0.26 | ||
| Q1 25 | $-0.14 | $0.10 | ||
| Q4 24 | $-1.86 | $-0.55 | ||
| Q3 24 | $1.07 | $-0.01 | ||
| Q2 24 | $1.43 | $0.06 | ||
| Q1 24 | $0.92 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $18.5M | $767.6M |
| 总债务越低越好 | $245.9M | $542.2M |
| 股东权益账面价值 | $718.4M | $2.1B |
| 总资产 | $1.2B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.34× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
MGPI
RGEN
| Q4 25 | $18.5M | $767.6M | ||
| Q3 25 | $13.4M | $748.7M | ||
| Q2 25 | $17.3M | $708.9M | ||
| Q1 25 | $20.1M | $697.2M | ||
| Q4 24 | $25.3M | $757.4M | ||
| Q3 24 | $20.8M | $784.0M | ||
| Q2 24 | $21.0M | $809.1M | ||
| Q1 24 | $19.5M | $780.6M |
总债务
MGPI
RGEN
| Q4 25 | $245.9M | $542.2M | ||
| Q3 25 | $262.3M | $537.9M | ||
| Q2 25 | $290.7M | — | ||
| Q1 25 | $290.7M | — | ||
| Q4 24 | $317.1M | $525.6M | ||
| Q3 24 | $283.6M | — | ||
| Q2 24 | $303.0M | — | ||
| Q1 24 | $294.4M | — |
股东权益
MGPI
RGEN
| Q4 25 | $718.4M | $2.1B | ||
| Q3 25 | $855.2M | $2.1B | ||
| Q2 25 | $841.8M | $2.1B | ||
| Q1 25 | $828.3M | $2.0B | ||
| Q4 24 | $834.2M | $2.0B | ||
| Q3 24 | $914.5M | $2.0B | ||
| Q2 24 | $894.5M | $2.0B | ||
| Q1 24 | $867.0M | $2.0B |
总资产
MGPI
RGEN
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $1.4B | $2.9B | ||
| Q2 25 | $1.4B | $2.9B | ||
| Q1 25 | $1.4B | $2.9B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | $1.4B | $2.8B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | $1.4B | $2.8B |
负债/权益比
MGPI
RGEN
| Q4 25 | 0.34× | 0.26× | ||
| Q3 25 | 0.31× | 0.26× | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.38× | 0.27× | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $29.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $24.3M | $17.6M |
| 自由现金流率自由现金流/营收 | 17.5% | 8.9% |
| 资本支出强度资本支出/营收 | 3.5% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $76.0M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
MGPI
RGEN
| Q4 25 | $29.1M | $25.7M | ||
| Q3 25 | $36.1M | $48.1M | ||
| Q2 25 | $11.7M | $28.6M | ||
| Q1 25 | $44.7M | $15.0M | ||
| Q4 24 | $28.8M | $39.2M | ||
| Q3 24 | $43.9M | $49.3M | ||
| Q2 24 | $5.0M | $42.2M | ||
| Q1 24 | $24.6M | $44.7M |
自由现金流
MGPI
RGEN
| Q4 25 | $24.3M | $17.6M | ||
| Q3 25 | $27.6M | $43.4M | ||
| Q2 25 | $-557.0K | $21.5M | ||
| Q1 25 | $24.8M | $11.4M | ||
| Q4 24 | $10.4M | $33.6M | ||
| Q3 24 | $24.5M | $42.3M | ||
| Q2 24 | $-1.4M | $37.4M | ||
| Q1 24 | $-2.4M | $36.4M |
自由现金流率
MGPI
RGEN
| Q4 25 | 17.5% | 8.9% | ||
| Q3 25 | 21.1% | 23.0% | ||
| Q2 25 | -0.4% | 11.8% | ||
| Q1 25 | 20.4% | 6.8% | ||
| Q4 24 | 5.8% | 19.3% | ||
| Q3 24 | 15.2% | 27.3% | ||
| Q2 24 | -0.7% | 24.3% | ||
| Q1 24 | -1.4% | 24.0% |
资本支出强度
MGPI
RGEN
| Q4 25 | 3.5% | 4.1% | ||
| Q3 25 | 6.5% | 2.5% | ||
| Q2 25 | 8.4% | 3.9% | ||
| Q1 25 | 16.4% | 2.1% | ||
| Q4 24 | 10.1% | 3.2% | ||
| Q3 24 | 12.0% | 4.5% | ||
| Q2 24 | 3.3% | 3.1% | ||
| Q1 24 | 15.8% | 5.5% |
现金转化率
MGPI
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 2.34× | 3.23× | ||
| Q2 25 | 0.81× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.84× | — | ||
| Q2 24 | 0.15× | 12.70× | ||
| Q1 24 | 1.19× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MGPI
| Branded Spirits | $63.4M | 46% |
| Ingredient Solutions | $31.3M | 23% |
| Specialty Wheat Starches | $16.8M | 12% |
| Mid Spirits | $16.1M | 12% |
| Other Branded Spirits | $8.0M | 6% |
| Commodity Wheat Starch | $2.3M | 2% |
RGEN
暂无分部数据